jama semaglutide naion - Most viewed this week from JAMA Ophthalmology: #Semaglutide, taken for diabetes or obesity, was associated with non-arteritic anterior ischemic optic neuropathy (NAION). https://ja.ma/4mO3NOU Specialists discuss concerns over impact

In the SURMOUNT-1 clinical trial, patients lost significant weight, with dose-dependent results ranging from approximately 15% to 20% of body weight over 72 weeks

Mantovani G, Isidori AM, Moretti C, Di Dato C, Greco E, Ciolli P, Bonomi M, Petrone L, Fumarola A, Campagna G, Vannucchi G, Di Sante S, Pozza C, Faggiano A, Lenzi A, Giannetta E

Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model

PMID: 40012609

Shapely is a personalized weight loss program in Flower Mound, Texas that takes a whole-person approach to losing weight and keeping it off

Our dedication to providing FDA-approved medications gives you peace of mind in your weight loss journey